Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengming Xu

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Frontiers in Cellular and Infection Microbiology|August 27, 2025
<i>Porphyromonas gingivalis</i> hijacks mitophagy and lysosomal function to persist in endothelial cellsCheng Zheng, Jianmin Huang, Shengming Xu, et al.
Theranostics|September 15, 2020
EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapyShuli Liu, Yang Wang, Yong Han, et al.
Journal of Periodontal Research|May 9, 2025
Porphyromonas gingivalis Induces Endothelial Dysfunction Through Sirt3-Dependent CypD AcetylationShengming Xu, Cheng Zheng, Jianmin Huang, et al.
Genes & Diseases|October 27, 2025
Identifying C1orf122 as a potential HCC exacerbated biomarker dependently of SRPK1 regulates PI3K/AKT/GSK3β signaling pathwayJing Cai, Li Rong, Runzhi Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 3, 2023
Meta-Lens Particle Image VelocimetryXiaoyuan Liu, Zhou Zhao, Shengming Xu, et al.
Clinical and Translational Medicine|January 27, 2024
Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinomaShengming Xu, Chaoji Shi, Rong Zhou, et al.
Cancer Communications (London, England)|June 6, 2022
Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell lineChaoji Shi, Ziyue Gu, Shengming Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2019
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic AberrationsRong Zhou, Chaoji Shi, Wenjie Tao, et al.
BMC Medicine|May 28, 2024
The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplificationChaoji Shi, Houyu Ju, Rong Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 13, 2025
CO-Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier IntegrityHongyang Lu, Qiang Zhou, Jiayu Li, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Frontiers in Cellular and Infection Microbiology|August 27, 2025
<i>Porphyromonas gingivalis</i> hijacks mitophagy and lysosomal function to persist in endothelial cellsCheng Zheng, Jianmin Huang, Shengming Xu, et al.
Theranostics|September 15, 2020
EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapyShuli Liu, Yang Wang, Yong Han, et al.
Journal of Periodontal Research|May 9, 2025
Porphyromonas gingivalis Induces Endothelial Dysfunction Through Sirt3-Dependent CypD AcetylationShengming Xu, Cheng Zheng, Jianmin Huang, et al.
Genes & Diseases|October 27, 2025
Identifying C1orf122 as a potential HCC exacerbated biomarker dependently of SRPK1 regulates PI3K/AKT/GSK3β signaling pathwayJing Cai, Li Rong, Runzhi Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 3, 2023
Meta-Lens Particle Image VelocimetryXiaoyuan Liu, Zhou Zhao, Shengming Xu, et al.
Clinical and Translational Medicine|January 27, 2024
Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinomaShengming Xu, Chaoji Shi, Rong Zhou, et al.
Cancer Communications (London, England)|June 6, 2022
Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell lineChaoji Shi, Ziyue Gu, Shengming Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2019
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic AberrationsRong Zhou, Chaoji Shi, Wenjie Tao, et al.
BMC Medicine|May 28, 2024
The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplificationChaoji Shi, Houyu Ju, Rong Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 13, 2025
CO-Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier IntegrityHongyang Lu, Qiang Zhou, Jiayu Li, et al.
Pageof 9